Femasys Inc. (FEMY) News
Follow Femasys Inc. (FEMY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 9 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Femasys doubles enrollment sites in FemBloc pivotal trial
Femasys doubled the number of enrolling sites in its FINALE pivotal trial for non-surgical permanent birth control.
EQUITY | Oct 14, 2026, 01:00 PM UTC
L
FEMY - Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
FEMY - Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
NEWS | Sep 15, 2026, 01:00 PM UTC
L
Femasys partners with CapexMD to expand FemaSeed patient access
Femasys said its collaboration with CapexMD will provide dedicated patient financing for its FemaSeed fertility solutions across OB/GYN practices and fertility centers, aiming to reduce financial barriers to care.
EQUITY | Sep 09, 2026, 01:03 PM UTC
L
FEMY partners with CapexMD to expand patient access
Femasys partners with CapexMD to expand patient access to its FemaSeed fertility portfolio.
EQUITY | Sep 09, 2026, 01:01 PM UTC
L
Femasys files SEC resale for up to 28,124,997 shares of common stock
Femasys (FEMY) filed an SEC registration for the resale of up to 28,124,997 shares of common stock.
REGULATION | Sep 03, 2026, 09:53 PM UTC
L
Femasys partners with UNC Health to expand FemaSeed fertility portfolio
Femasys Partners with UNC Health to introduce its FemaSeed fertility portfolio across statewide OB/GYN care locations.
EQUITY | Aug 26, 2026, 01:00 PM UTC
M
Femasys FDA approves modular PMA submission approach for FemBloc®
Femasys announces FDA approval of a modular PMA submission approach for its FemBloc® device.
REGULATION | Aug 19, 2026, 01:00 PM UTC
L
Femasys reports quarter ended June 30, 2026 financial results
Femasys announces financial results for the quarter ended June 30, 2026 and provides a corporate update.
EARNINGS | Aug 14, 2026, 08:05 PM UTC
L
FEMY Strengthens Patent Protection
Femasys strengthens global patent protection for FemBloc with issued blended polymer patents
EQUITY | Aug 12, 2026, 01:00 PM UTC
L
FEMY Regains Compliance
Femasys regains compliance with Nasdaq listing requirements
REGULATION | Jun 24, 2026, 01:00 PM UTC